Skip to Content

B 251 (Phenazopyridine plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)

Pill imprint B 251 has been identified as Phenazopyridine plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg.

Butabarbital/hyoscyamine/phenazopyridine is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. Butabarbital/hyoscyamine/phenazopyridine butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Phenazopyridine plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg B 251
Discount Card Promo
Phenazopyridine plus
Imprint:
B 251
Strength:
butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Breckenridge Pharmaceutical, Inc.

More info Print Imprint Search

More about butabarbital/hyoscyamine/phenazopyridine

Consumer resources

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide